Advanced search
Publication Cover
Nanomedicine Volume 9, 2014 - Issue 11
Submit an article Journal homepage
159
Views
0
CrossRef citations to date
0
Altmetric
Preliminary Communication

Comparative Biophysical Properties of Tenofovir-Loaded, Thiolated and Nonthiolated Chitosan Nanoparticles Intended for HIV Prevention

Jianing Meng1 Laboratory of Future Nanomedicines & Theoretical Chronopharmaceutics, Division of Pharmaceutical Sciences, University of Missouri, Kansas City, MO64108, USAView further author information
,
Tao Zhang1 Laboratory of Future Nanomedicines & Theoretical Chronopharmaceutics, Division of Pharmaceutical Sciences, University of Missouri, Kansas City, MO64108, USAView further author information
,
Vivek Agrahari1 Laboratory of Future Nanomedicines & Theoretical Chronopharmaceutics, Division of Pharmaceutical Sciences, University of Missouri, Kansas City, MO64108, USAView further author information
,
Miezan J Ezoulin1 Laboratory of Future Nanomedicines & Theoretical Chronopharmaceutics, Division of Pharmaceutical Sciences, University of Missouri, Kansas City, MO64108, USAView further author information
&
Bi-Botti C Youan1 Laboratory of Future Nanomedicines & Theoretical Chronopharmaceutics, Division of Pharmaceutical Sciences, University of Missouri, Kansas City, MO64108, USACorrespondence[email protected]
View further author information
Pages 1595-1612 | Received 22 May 2012, Accepted 13 Jun 2013, Published online: 16 Oct 2014

References

  • Hackley VA , FerrarisCF. The Use of Nomenclature in Dispersion Science and Technology. NIST Recommended Practice Guide. National Institute of Standards and Technology, Washington DC, USA (2001).
  • UNAIDS. Introduction. In: Global Report UNAIDS Report on the Global AIDS Epidemic 2013. UNAIDS, Geneva, Switzerland, 4–11 (2013).
  • Krishnan S , DunbarMS, MinnisAM, MedlinCA, GerdtsCE, PadianNS. Poverty, gender inequities, and women‘s risk of human immunodeficiency virus/AIDS. Ann. NY Acad. Sci.1136, 101–110 (2008).
  • UNAIDS. Eliminate gender inequalities and gender-based abuse and violence and increase thecapacity of women and girls to protect themselves from HIV. In: Global Report UNAIDS Report on the Global AIDS Epidemic 2013. UNAIDS, Geneva, Switzerland, 78–83 (2013).
  • Askew I , BererM. The contribution of sexual and reproductive health services to the fight against HIV/AIDS: a review. Reprod. Health Matt.11(22), 51–73 (2003).
  • Weber J , DesaiK, DarbyshireJ. The development of vaginal microbicides for the prevention of HIV transmission. PLoS Med.2(5), e142 (2005).
  • Ndesendo VM , PillayV, ChoonaraYE, BuchmannE, BayeverDN, MeyerLC. A review of current intravaginal drug delivery approaches employed for the prophylaxis of HIV/AIDS and prevention of sexually transmitted infections. AAPS PharmSciTech9(2), 505–520 (2008).
  • Mamo T , MosemanEA, KolishettiNet al. Emerging nanotechnology approaches for HIV/AIDS treatment and prevention. Nanomedicine (Lond.) 5(2), 269–285 (2010).
  • Zhang T , SturgisTF, YouanBB. pH-responsive nanoparticles releasing tenofovir intended for the prevention of HIV transmission. Eur. J. Pharm. Biopharm.79(3), 526–536 (2011).
  • Alukda D , SturgisT, YouanBB. Formulation of tenofovir-loaded functionalized solid lipid nanoparticles intended for HIV prevention. J. Pharm. Sci.100(8), 3345–3356 (2011).
  • Sosnik A . Nanotechnology contributions to the pharmacotherapy of pediatric HIV: a dual scientific and ethical challenge and a still pending agenda. Nanomedicine (Lond.)5(6), 833–837 (2010).
  • Murugeshu A , AsteteC, LeonardiC, MorganT, SabliovCM. Chitosan/PLGA particles for controlled release of alpha-tocopherol in the GI tract via oral administration. Nanomedicine (Lond.)6(9), 1513–1528 (2011).
  • Roldo M , HornofM, CalicetiP, Bernkop-SchnurchA. Mucoadhesive thiolated chitosans as platforms for oral controlled drug delivery: synthesis and in vitro evaluation. Eur. J. Pharm. Biopharm.57(1), 115–121 (2004).
  • Bernkop-Schnurch A . Thiomers: a new generation of mucoadhesive polymers. Adv. Drug Deliv. Rev.57(11), 1569–1582 (2005).
  • Leitner VM , WalkerGF, Bernkop-SchnurchA. Thiolated polymers: evidence for the formation of disulphide bonds with mucus glycoproteins. Eur. J. Pharm. Biopharm.56(2), 207–214 (2003).
  • Meng J , SturgisTF, YouanBB. Engineering tenofovir loaded chitosan nanoparticles to maximize microbicide mucoadhesion. Eur.J. Pharm. Sci.44(1–2), 57–67 (2011).
  • Grim SA , RomanelliF. Tenofovir disoproxil fumarate. Ann. Pharmacother.37(6), 849–859 (2003).
  • Jang KI , LeeHG. Stability of chitosan nanoparticles for l-ascorbic acid during heat treatment in aqueous solution. J. Agric. Food Chem.56(6), 1936–1941 (2008).
  • Fernandez-Urrusuno R , CalvoP, Remunan-LopezC, Vila-JatoJL, AlonsoMJ. Enhancement of nasal absorption of insulin using chitosan nanoparticles. Pharm. Res.16(10), 1576–1581 (1999).
  • Thongborisute J , TakeuchiH, YamamotoH, KawashimaY. Visualization of the penetrative and mucoadhesive properties of chitosan and chitosan-coated liposomes through the rat intestine. J. Liposome Res.16(2), 127–141 (2006).
  • Ma Z , LimLY. Uptake of chitosan and associated insulin in Caco-2 cell monolayers: a comparison between chitosan molecules and chitosan nanoparticles. Pharm. Res.20(11), 1812–1819 (2003).
  • Kätzel U , VorbauM, StintzM, Gottschalk-GaudigT, BarthelH. Dynamic light scattering for the characterization of polydisperse fractal systems: II. Relation between structure and DLS results. Part. Syst. Charact.25, 19–30 (2008).
  • Sassi AB , IsaacsCE, MonclaBJ, GuptaP, HillierSL, RohanLC. Effects of physiological fluids on physical–chemical characteristics and activity of topical vaginal microbicide products. J. Pharm. Sci.97(8), 3123–3139 (2008).
  • Don TM , HsuSH, ChiuWY. Structures and thermal properties of chitosan-modified poly(methyl methacrylate). J. Polym. Sci.39, 1646–1655 (2001).
  • Nayak AK , LahaB, SenKK. Development of hydroxyapatite-ciprofloxacin bone-implants using ‘quality by design‘. Acta Pharm.61(1), 25–36 (2011).
  • Lackman-Smith C , OsterlingC, LuckenbaughKet al. Development of a comprehensive human immunodeficiency virus type 1 screening algorithm for discovery and preclinical testing of topical microbicides. Antimicrob. Agents Chemother. 52(5), 1768–1781 (2008).
  • Jorgenson JH , TurnidgeJD, WashingtonJAet al.: Antibacterial susceptibility tests: dilution and disk diffusion methods. In: Manual of Clinical Microbiology (Seventh Edition). Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH (Eds). ASM Press, Washington DC, USA, 1327–1341 (1999).
  • Xie J , WangCH. Self-assembled biodegradable nanoparticles developed by direct dialysis for the delivery of paclitaxel. Pharm. Res.22(12), 2079–2090 (2005).
  • Pifer MA , KibuuleLK, MaerzT, StudzinskiDM, BakerKC, HerkowitzHN. In vitro response of human chondrocytes to a combination of growth factors and a proteinase inhibitor. Orthopedics35(1), 35–42 (2012).
  • Douglas KL , PiccirilloCA, TabrizianM. Cell line-dependent internalization pathways and intracellular trafficking determine transfection efficiency of nanoparticle vectors. Eur. J. Pharm. Biopharm.68(3), 676–687 (2008).
  • Ranga Rao KV , BuriP. A novel in situ method to test polymers and coated microparticles for bioadhesion. Endocr. Rev.52 15(13), 265–270 (1989).
  • Albrecht K , ZirmEJ, PalmbergerTF, SchlockerW, Bernkop-SchnurchA. Preparation of thiomer microparticles and in vitro evaluation of parameters influencing their mucoadhesive properties. Drug. Dev. Ind. Pharm.32(10), 1149–1157 (2006).
  • Grabovac V , GuggiD, Bernkop-SchnurchA. Comparison of the mucoadhesive properties of various polymers. Adv. Drug Deliv. Rev.57(11), 1713–1723 (2005).
  • Dudhania A , KosarajuS. Bioadhesive chitosan nanoparticles: preparation and characterization. Carbohyd. Polym.81, 243–251 (2010).
  • Lopes LB , FerreiraDA, De Paula D et al. Reverse hexagonal phase nanodispersion of monoolein and oleic acid for topical delivery of peptides: in vitro and in vivo skin penetration of cyclosporin A. Pharm. Res.23(6), 1332–1342 (2006).
  • Montgomery D . Response surface methods and design. In: Design and Analysis of Experiments. John Wiley and Sons Inc., NY, USA, 405–458 (1995).
  • Ferreira SL , BrunsRE, Da Silva EG et al. Statistical designs and response surface techniques for the optimization of chromatographic systems. J. Chromatogr. A1158(1–2), 2–14 (2007).
  • Vander Heyden Y , NijhuisA, Smeyers-VerbekeJ, VandeginsteBG, MassartDL. Guidance for robustness/ruggedness tests in method validation. J. Pharm. Biomed. Anal.24(5–6), 723–753 (2001).
  • Miller JN , MillerJC. Significance tests. In: Statistics and Chemometrics for Analytical Chemistry (Fifth Edition). Pearson Education, NJ, USA, 39–69 (2010).
  • Bei D , MarszalekJ, YouanBB. Formulation of dacarbazine-loaded cubosomes – part II: influence of process parameters. AAPS PharmSciTech10(3), 1040–1047 (2009).
  • Nagarwal RC , SinghPN, KantS, MaitiP, PanditJK. Chitosan nanoparticles of 5-fluorouracil for ophthalmic delivery: characterization, in-vitro and in-vivo study. Chem. Pharm. Bull. (Tokyo)59(2), 272–278 (2011).
  • Choi SU , BuiT, HoRJ. pH-dependent interactions of indinavir and lipids in nanoparticles and their ability to entrap a solute. J. Pharm. Sci.97(2), 931–943 (2008).
  • Van Gelder J , WitvrouwM, PannecouqueCet al. Evaluation of the potential of ion pair formation to improve the oral absorption of two potent antiviral compounds, AMD3100 and PMPA. Int. J. Pharm. 186(2), 127–136 (1999).
  • Cleland WW . Dithiothreitol, a new protective reagent for Sh groups. Biochemistry3, 480–482 (1964).
  • Hu B , PanC, SunY, HouZ, YeH, ZengX. Optimization of fabrication parameters to produce chitosan-tripolyphosphate nanoparticles for delivery of tea catechins. J. Agric. Food. Chem.56(16), 7451–7458 (2008).
  • Nasti A , ZakiNM, De Leonardis P et al. Chitosan/TPP and chitosan/TPP-hyaluronic acid nanoparticles: systematic optimisation of the preparative process and preliminary biological evaluation. Pharm. Res.26(8), 1918–1930 (2009).
  • Abdool Karim Q , Abdool Karim SS, Frohlich JA et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science329(5996), 1168–1174 (2010).
  • Costa P , Sousa Lobo JM. Modeling and comparison of dissolution profiles. Eur. J. Pharm. Sci.13(2), 123–133 (2001).
  • Merchant HA , ShoaibHM, TazeenJ, YousufR. Once-daily tablet formulation and in vitro release evaluation of cefpodoxime using hydroxypropyl methylcellulose: a technical note. AAPS PharmSciTech7(3), 78 (2006).
  • Baloglu E , SenyigitZA, KaravanaSY, Bernkop-SchnurchA. Strategies to prolong the intravaginal residence time of drug delivery systems. J. Pharm. Sci.12(3), 312–336 (2009).
  • Lee WA , HeGX, EisenbergEet al. Selective intracellular activation of a novel prodrug of the human immunodeficiency virus reverse transcriptase inhibitor tenofovir leads to preferential distribution and accumulation in lymphatic tissue. Antimicrob. Agents Chemother. 49(5), 1898–1906 (2005).
  • Uboldi C , BonacchiD, LorenziGet al. Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441. Part Fibre Toxicol. 6, 18 (2009).
  • Au C , MutkusL, DobsonA, RiffleJ, LalliJ, AschnerM. Effects of nanoparticles on the adhesion and cell viability on astrocytes. Biol. Trace Elem. Res.120(1–3), 248–256 (2007).
  • Wilks M , WigginsR, WhileyAet al. Identification and H2O2 production of vaginal lactobacilli from pregnant women at high risk of preterm birth and relation with outcome. J. Clin. Microbiol. 42(2), 713–717 (2004).
  • Verhelst R , VerstraelenH, ClaeysGet al. Comparison between Gram stain and culture for the characterization of vaginal microflora: definition of a distinct grade that resembles grade I microflora and revised categorization of grade I microflora. BMC Microbiol. 5, 61 (2005).
  • Casella JF , FlanaganMD, LinS. Cytochalasin D inhibits actin polymerization and induces depolymerization of actin filaments formed during platelet shape change. Nature293(5830), 302–305 (1981).
  • Luxford KA , MurphyCR. Cytoskeletal control of the apical surface transformation of rat uterine epithelium. Biol. Cell79(2), 111–116 (1993).
  • Meng H , YangS, LiZet al. Aspect ratio determines the quantity of mesoporous silica nanoparticle uptake by a small GTPase-dependent macropinocytosis mechanism. ACS Nano 5(6), 4434–4447 (2011).
  • Mercer J , HeleniusA. Virus entry by macropinocytosis. Nat. Cell Biol.11(5), 510–520 (2009).
  • Perumal OP , InapagollaR, KannanS, KannanRM. The effect of surface functionality on cellular trafficking of dendrimers. Biomaterials29(24–25), 3469–3476 (2008).
  • Pho MT , AshokA, AtwoodWJ. JC virus enters human glial cells by clathrin-dependent receptor-mediated endocytosis. J. Virol.74(5), 2288–2292 (2000).
  • Benmerah A , LamazeC. Clathrin-coated pits: vive la difference? Traffic8(8), 970–982 (2007).
  • Manes S , Del Real G, Martinez AC. Pathogens: raft hijackers. Nat. Rev. Immunol.3(7), 557–568 (2003).
  • Rybin VO , GrabhamPW, ElouardighiH, SteinbergSF. Caveolae-associated proteins in cardiomyocytes: caveolin-2 expression and interactions with caveolin-3. Am. J. Physiol. Heart Circ. Physiol.285(1), H325–H332 (2003).
  • Georgieva JV , KalicharanD, CouraudPOet al. Surface characteristics of nanoparticles determine their intracellular fate in and processing by human blood–brain barrier endothelial cells in vitro. Mol. Ther. 19(2), 318–325 (2011).
  • Rejman J , OberleV, ZuhornIS, HoekstraD. Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem. J.377(Pt 1), 159–169 (2004).
  • Bathori G , CervenakL, KaradiI. Caveolae – an alternative endocytotic pathway for targeted drug delivery. Crit. Rev. Ther. Drug Carrier Syst.21(2), 67–95 (2004).
  • Peng SF , TsengMT, HoYC, WeiMC, LiaoZX, SungHW. Mechanisms of cellular uptake and intracellular trafficking with chitosan/DNA/poly(gamma-glutamic acid) complexes as a gene delivery vector. Biomaterials32(1), 239–248 (2011).
  • Hammes A , AndreassenTK, SpoelgenRet al. Role of endocytosis in cellular uptake of sex steroids. Cell 122(5), 751–762 (2005).
  • Dekker J , RossenJW, BullerHA, EinerhandAW. The MUC family: an obituary. Trends Biochem. Sci.27(3), 126–131 (2002).
  • Bernkop-Schnurch A , SchwarzV, SteiningerS. Polymers with thiol groups: a new generation of mucoadhesive polymers? Pharm. Res.16(6), 876–881 (1999).
  • Squier CA , MantzMJ, SchlievertPM, DavisCC. Porcine vagina ex vivo as a model for studying permeability and pathogenesis in mucosa. J. Pharm. Sci.97(1), 9–21 (2008).
  • Nicolazzo JA , ReedBL, FinninBC. The effect of various in vitro conditions on the permeability characteristics of the buccal mucosa. J. Pharm. Sci.92(12), 2399–2410 (2003).
  • Lesch CA , SquierCA, CruchleyA, WilliamsDM, SpeightP. The permeability of human oral mucosa and skin to water. J. Dent. Res.68(9), 1345–1349 (1989).
  • Bernkop-Schnurch A , HornofM, GuggiD. Thiolated chitosans. Eur. J. Pharm. Biopharm.57(1), 9–17 (2004).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.